Jing Lin
Impact in
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
- Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism
Papers in
- Microbiology 17
- Antimicrobial Peptides and Activities 17
-
- Antibiotic Resistance in Bacteria 13
- Co-authors
- Wei‐Min ChenHaimin ChenMichael NovákXiaojun YanZhi‐Shu HuangJinghai J. XuLian‐Quan GuSteven M. Winter
- Journals
- European Journal of Medicinal Chemistry (12 papers)Journal of Medicinal Chemistry (11 papers)MedChemComm (4 papers)Biochemical and Biophysical Research Communications (3 papers)Journal of the American Chemical Society (3 papers)
- Partner nations
- ChinaUnited StatesThailand
In The Last Decade
Jing Lin
94 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 132
- Molecular Medicine 179
- Pharmacology 247
- Microbiology 135
- Toxicology 68
- Organic Chemistry 547
Countries citing papers authored by Jing Lin
This map shows the geographic impact of Jing Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jing Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jing Lin more than expected).
Fields of papers citing papers by Jing Lin
This network shows the impact of papers produced by Jing Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jing Lin. The network helps show where Jing Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Jing Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 7 | |
| 2 | 2024 | 7 | |
| 3 | 2022 | 17 | |
| 4 | 2020 | 7 | |
| 5 | 2020 | 6 | |
| 6 | 2020 | 11 | |
| 7 | 2020 | 10 | |
| 8 | 2019 | 48 | |
| 9 | 2019 | 14 | |
| 10 | 2018 | 33 | |
| 11 | 2018 | 4 | |
| 12 | 2017 | 15 | |
| 13 | 2016 | 27 | |
| 14 | 2015 | 7 | |
| 15 | 2015 | 31 | |
| 16 | 2015 | 30 | |
| 17 | 2013 | 16 | |
| 18 | 2013 | 39 | |
| 19 | 2010 | 24 | |
| 20 | 2003 | 221 |
About Jing Lin
Jing Lin is a scholar working on Microbiology, Molecular Medicine, Toxicology, Pharmacology and Molecular Biology, having authored 95 papers that have together received 2.6k indexed citations. Recurring topics across this work include Bacterial biofilms and quorum sensing (18 papers), Antimicrobial Peptides and Activities (17 papers), Antibiotic Resistance in Bacteria (13 papers), DNA and Nucleic Acid Chemistry (11 papers), RNA Interference and Gene Delivery (7 papers), Advanced biosensing and bioanalysis techniques (6 papers), Bioactive Compounds and Antitumor Agents (5 papers) and Analytical Chemistry and Chromatography (4 papers). The work is most often cited by research in Molecular Medicine (179 citations), Pharmacology (247 citations), Microbiology (135 citations), Toxicology (68 citations) and Organic Chemistry (547 citations). Jing Lin has collaborated with scholars based in China, United States and Thailand. Frequent co-authors include Wei‐Min Chen, Haimin Chen, Michael Novák, Xiaojun Yan, Zhi‐Shu Huang, Jinghai J. Xu, Lian‐Quan Gu, Steven M. Winter, R J Polzer and Tian‐Miao Ou. Their work appears in journals such as European Journal of Medicinal Chemistry, Journal of Medicinal Chemistry, MedChemComm, Biochemical and Biophysical Research Communications and Journal of the American Chemical Society.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.